Phase II trial: Concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck

Clinical and Translational Oncology

Volumn 9, Issue 4, 2007, Pages 244-250

  Biete Sola A ^a   Marruecos Querol, J ^a   Calvo Manuel, F A ^b   Verger Fransoy, E ^a   Rovirosa Casino, A ^a   Grau de Castro, J J ^c   Heras Gonzalez M ^d   Ramos Aguerri, A ^e   Palacios Eito, A ^f   Veiras Candal, C ^g   Solano Lopez M V ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

^f HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^g Hospital Oncologico de Galicia   (Spain)

Author keywords

Docetaxel; Squamous cell carcinoma of head and neck; Toxicity; Treatment

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; DEXAMETHASONE; DOCETAXEL; SEROTONIN 3 ANTAGONIST; ANTINEOPLASTIC AGENT; TAXOID;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; BONE NECROSIS; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG FATALITY; DYSPHAGIA; ESOPHAGITIS; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; INCIDENCE; LEUKOPENIA; LIVER TOXICITY; LYMPHOCYTOPENIA; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; ODYNOPHAGIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PNEUMONIA; RADIATION DOSE; SKIN TOXICITY; SPAIN; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; THROMBOCYTOPENIA; TISSUE NECROSIS; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR LOCALIZATION; XEROSTOMIA; CANCER STAGING; COMPARATIVE STUDY; HEAD AND NECK TUMOR; KAPLAN MEIER METHOD; KARNOFSKY PERFORMANCE STATUS; LARYNX; LARYNX TUMOR; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIPLE CANCER; PATHOLOGY; PHARYNX; PHARYNX CANCER; RADIOTHERAPY; TIME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIERS ESTIMATE; KARNOFSKY PERFORMANCE STATUS; LARYNGEAL NEOPLASMS; LARYNX; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PHARYNGEAL NEOPLASMS; PHARYNX; RADIOTHERAPY; RADIOTHERAPY DOSAGE; TAXOIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34447107628     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0047-y     Document Type: Article

References (32)

1. Pignon JP, Baujat B, Bourhis J (2005) Individual patient data meta-analyses in head and neck carcinoma: What have we learnt? Cancer Radiother 9:31-36
2. El-Sayed S, Nelson N (1996) Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 14:838-847
3. Al-Sarraf M, LeBlanc M, Giri PG et al (1998) Chemotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 16:1310-1317
4. Adelstein DJ, Li Y, Adams GL et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92-98
5. Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098
6. Cooper JS, Pajak TF, Forastiere AA et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937-1944
7. Bernier J, Domenge C, Ozsahin M et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945-1952
8. Glisson BS, Murphy BA, Frenette G et al (2002) Phase II trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck. J Clin Oncol 20:1593-1599
9. Colevas AD, Norris CM, Tishler RB et al (1999) Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck. J Clin Oncol 17:3503-3511
10. Ringel I, Horwitz SB (1991) Studies with RP 56976 (taxotere): A semisynthetic analogue of taxol. J Natl Cancer Inst 83:288-291
11. Gueritte-Voegelein F, Guenard D, Lavelle F et al (1991) Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem 34:992-998
12. Hennequin C (2004) Association of taxanes and radiotherapy: Preclinical and clinical studies. Cancer Radiother 8[Suppl 1]:S95-105
13. Chaffey JT, Hellman S (1971) Differing responses to radiation of murine bone marrow stem cells in relation to the cell cycle. Cancer Res 31:1613-1615
14. Calais G, Alfonsi M, Bardet E et al (1999) Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma. J Natl Cancer Inst 91:2081-2086
15. Brizel DM, Albers ME, Fisher SR et al (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804
16. Adelstein DJ, Saxton JP, Lavertu P et al (1997) A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results. Head Neck 19:567-575
17. Wendt TG, Grabenbauer GG, Rodel CM et al (1998) Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer. A randomized multicentric study. J Clin Oncol 16:1318-1324
18. Jeremic B, Shibamoto Y, Stanisavljevic B et al (1997) Radiation therapy alone or with concurrent low-dose daily either Cisplatin or Carboplatin in locally advanced unresectable squamous cell carcinoma of head and neck: A prospective randomized trial. Radiother Oncol 43:29-37
19. Bissery MC, Nohynek G, Sanderink GJ, Lavelle F (1995) Docetaxel (Taxotere): A review of preclinical and clinical experience. Part I: Preclinical experience. Anticancer Drugs 6:339-368
20. Hanauske AR, Degen D, Hilsenbeck SG et al (1992) Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells. Anti-cancer Drugs 3:121-124
21. Schoffski P, Weihkopf T, Ganser A (1998) Advanced head and neck cancer and clinical experience of an effective new agent: Docetaxel. Anticancer Res 18:4751-4756
22. Kodaira T, Fuwa N, Furutani K et al (2005) Phase I trial of weekly docetaxel and concurrent radiotherapy for head and neck cancer in elderly patients or patients with complications. Jpn J Clin Oncol 35:173-176
23. Kovacs AF, Mose S, Bottcher HD, Bitter K (2005) Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer. Strahlenther Onkol 181:26-34
24. Fujii M, Tsukuda M, Satake B et al (2004) Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck. Int J Clin Oncol 9: 107-112
25. Inohara H, Inoue T, Akahani S et al (2004) Concurrent chemoradiotherapy with cisplatin and docetaxel for advanced head and neck cancer. A phase I study. Anticancer Res 24:4135- 4140
26. Airoldi M, Cattel L, Cortesina G et al (2004) Docetaxel, carboplatin and concomitant radiotherapy for unresectable squamous cell carcinoma of the head and neck: Pharmacokinetic and clinical data of a phase I-II study. Am J Clin Oncol 27:155-163
27. Katori H, Tsukuda M, Mochimatu I et al (2004) Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Br J Cancer 90:348-352
28. Katori H, Tsukuda M (2005) Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck. Clin Oncol (R Coll Radiol) 17:148-152
29. Schwartz DL, Montgomery RB, Yueh B et al (2005) Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Cancer 103:2534-2543
30. Schrijvers D, Van Herpen C, Kerger J et al (2004) Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: A phase I-II feasibility study. Ann Oncol 15:638-645
31. Medina JA, Rueda A, de Pasos AS et al (2006) A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas. Radiother Oncol 79:34-38
32. Allal AS, Zwahlen D, Becker M et al (2006) Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck cancer. Cancer J 12:63-68